Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05408247
PHASE4
A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
Sponsor: University of Sydney
View on ClinicalTrials.gov
Summary
To explore the effectiveness of n-acetylcysteine in improving treatment outcomes for alcohol use disorder in a double-blind randomised placebo-controlled trial.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
280
Start Date
2023-02-16
Completion Date
2026-11
Last Updated
2023-03-16
Healthy Volunteers
No
Conditions
Interventions
DRUG
N-acetyl cysteine
2400mg/day
DRUG
Placebo
Matched placebo
Locations (3)
Drug Health Services, Royal Prince Alfred Hospital
Sydney, New South Wales, Australia
Cornwall Street Medical Centre (UQ Health Care)
Annerley, Queensland, Australia
Turning Point
Richmond, Victoria, Australia